Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1269662-73-8
2. Shr-1258
3. Cjn36eqm0h
4. Shr1258
5. 1269662-73-8 (free Base)
6. (r,e)-n-(4-((3-chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-3-(1-methylpyrrolidin-2-yl)acrylamide
7. 2-propenamide, N-(4-((3-chloro-4-(2-pyridinylmethoxy)phenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-3-((2r)-1-methyl-2-pyrrolidinyl)-, (2e)-
8. Pyrotinib Racemate
9. (e)-n-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-ethoxyquinolin-6-yl]-3-[(2r)-1-methylpyrrolidin-2-yl]prop-2-enamide
10. Unii-cjn36eqm0h
11. Airuini
12. 1246089-97-3
13. Pyrotinib(shr-1258)
14. Pyrotinib [who-dd]
15. Gtpl9662
16. Schembl9948753
17. Chembl3647420
18. Bdbm139991
19. Bcp29458
20. Wzb08997
21. S8852
22. Cs-7940
23. Db14993
24. Compound 12 [pmid: 28115222]
25. Hy-104065
26. 4679b
27. A17068
28. Us8901140, 5
29. Shr-1258; Shr1258; Shr 1258
30. Q27275495
31. (e)-n-[4-[[3-chloro-4-(2-pyridylmethoxy)phenyl]amino]-3-cyano-7-ethoxy-6-quinolyl]-3-[(2r)-1-methylpyrrolidin-2-yl]prop-2-enamide
| Molecular Weight | 583.1 g/mol |
|---|---|
| Molecular Formula | C32H31ClN6O3 |
| XLogP3 | 5.4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 10 |
| Exact Mass | 582.2146166 g/mol |
| Monoisotopic Mass | 582.2146166 g/mol |
| Topological Polar Surface Area | 112 Ų |
| Heavy Atom Count | 42 |
| Formal Charge | 0 |
| Complexity | 960 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Pyrotinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pyrotinib, including repackagers and relabelers. The FDA regulates Pyrotinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pyrotinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pyrotinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pyrotinib supplier is an individual or a company that provides Pyrotinib active pharmaceutical ingredient (API) or Pyrotinib finished formulations upon request. The Pyrotinib suppliers may include Pyrotinib API manufacturers, exporters, distributors and traders.
click here to find a list of Pyrotinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Pyrotinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pyrotinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pyrotinib GMP manufacturer or Pyrotinib GMP API supplier for your needs.
A Pyrotinib CoA (Certificate of Analysis) is a formal document that attests to Pyrotinib's compliance with Pyrotinib specifications and serves as a tool for batch-level quality control.
Pyrotinib CoA mostly includes findings from lab analyses of a specific batch. For each Pyrotinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pyrotinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Pyrotinib EP), Pyrotinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pyrotinib USP).
LOOKING FOR A SUPPLIER?
